
UC Irvine study reveals surge in use of weight loss-linked drugs in California health system
"The results from our study of a large, diverse, statewide health system population promise to reshape the conversation around weight loss-associated GLP-1 RAs, informing healthcare stakeholders, policymakers, legislators, providers and patients alike." (Jonathan Watanabe)